Correlation Between ABVC Biopharma and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ABVC Biopharma and Processa Pharmaceuticals, you can compare the effects of market volatilities on ABVC Biopharma and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Processa Pharmaceuticals.

Diversification Opportunities for ABVC Biopharma and Processa Pharmaceuticals

0.61

Correlation Coefficient

ABVC Biopharma  Processa Pharmaceuticals

Poor diversification

The 3 months correlation between ABVC and Processa is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between ABVC Biopharma and Processa Pharmaceuticals

Given the investment horizon of 90 days ABVC Biopharma is expected to generate 1.25 times more return on investment than Processa Pharmaceuticals. However, ABVC Biopharma is 1.25 times more volatile than Processa Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  66.00  in ABVC Biopharma on September 3, 2024 and sell it today you would lose (13.00) from holding ABVC Biopharma or give up 19.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

ABVC Biopharma  vs.  Processa Pharmaceuticals

ABVC Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Processa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with ABVC Biopharma and Processa Pharmaceuticals

The main advantage of trading using opposite ABVC Biopharma and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind ABVC Biopharma and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.